Marija Popovic
Global Regulatory Strategy Leader in Oncology, Early and Late Phase @Eli Lilly and Company
Indianapolis, IN, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Jul 2024 — Present
Global Regulatory Strategy Leader in Oncology, Early and Late Phase @Eli Lilly and Company
View department →
Indianapolis, IN, US
EDUCATION
2000 — 2006
University of Toronto
PhD, Pharmaceutical Sciences/Immunotoxicology
2009 — 2017
American Board of Toxicology
DABT, Toxicology
2021 — 2021
Harvard Business School Online
Certificate in Leadership Principles
1996 — 2000
University of Toronto
HBSc, Human Biology
SKILLS
Cell BiologyBiotechnologyDiabetesValidationDrug DeliveryVaccinesMolecular BiologyGlpCRORegulatory AffairsLifesciencesMedical WritingOncologyClinical TrialsElisaClinical DevelopmentNeuroscienceBiochemistryInfectious DiseasesPharmacovigilanceTechnology TransferBiomarkersIndHplcPharmaceutical IndustrySopFdaPharmacokineticsToxicologyClinical PharmacologyRegulatory SubmissionsIn VivoPharmaceuticsDrug DiscoveryTherapeutic AreasPharmacologyCell CultureProtein ChemistryCellDrug Development
ABOUT MARIJA POPOVIC
Global Regulatory Lead in Oncology
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.